Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06BGU
|
|||
| Former ID |
DNC009200
|
|||
| Drug Name |
(+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one
|
|||
| Synonyms |
CHEMBL454297; (+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H17NO2
|
|||
| Canonical SMILES |
C=CCCC1CN(C1=O)C(=O)CCC=C
|
|||
| InChI |
1S/C12H17NO2/c1-3-5-7-10-9-13(12(10)15)11(14)8-6-4-2/h3-4,10H,1-2,5-9H2
|
|||
| InChIKey |
GINOGVHXZZDXCD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.